Quinoxaline-substituted chalcones as new inhibitors of breast cancer resistance protein ABCG2: polyspecificity at B-ring position

喹喔啉取代查尔酮作为乳腺癌耐药蛋白 ABCG2 的新抑制剂:B 环位置的多特异性

阅读:6
作者:Evelyn Winter, Gustavo Jabor Gozzi, Louise Domeneghini Chiaradia-Delatorre, Nathalia Daflon-Yunes, Raphael Terreux, Charlotte Gauthier, Alessandra Mascarello, Paulo César Leal, Silvia M Cadena, Rosendo Augusto Yunes, Ricardo José Nunes, Tania Beatriz Creczynski-Pasa, Attilio Di Pietro

Abstract

A series of chalcones substituted by a quinoxaline unit at the B-ring were synthesized and tested as inhibitors of breast cancer resistance protein-mediated mitoxantrone efflux. These compounds appeared more efficient than analogs containing other B-ring substituents such as 2-naphthyl or 3,4-methylenedioxyphenyl while an intermediate inhibitory activity was obtained with a 1-naphthyl group. In all cases, two or three methoxy groups had to be present on the phenyl A-ring to produce a maximal inhibition. Molecular modeling indicated both electrostatic and steric positive contributions. A higher potency was observed when the 2-naphthyl or 3,4-methylenedioxyphenyl group was shifted to the A-ring and methoxy substituents were shifted to the phenyl B-ring, indicating preferences among polyspecificity of inhibition.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。